Chronic Kidney Disease Mineral and Bone Disorder
10
2
2
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (10)
Phosphate Assessment in Chronic Kidney Disease Patients Study
The Effect of REgulation of PArathyroId hoRmone in Patients With Chronic Kidney Disease to Investigate the Change in Bone Mineral Density
The CPH-MBD Cohort
Calcium and Phosphorus Whole-Body Balance and Kinetics in Patients With Moderate Chronic Kidney Disease
Impact of Parathyroidectomy on Cardiovascular Calcification in Dialysis-dependent Patients
The Effect of Etelcalcetide on CKD-MBD
Calcium Balance Studies in Children With CKD and on Dialysis
Pathogenesis of Compromised Bone Quality and Mechanics in Chronic Kidney Disease
Phosphorus Absorption in Healthy Adults and in Patients With Moderate Chronic Kidney Disease
Artificial Intelligence: a New Alternative to Analyse CKD-MBD in Hemodialysis